{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:46:40Z","timestamp":1762307200287,"version":"build-2065373602"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,4]]},"DOI":"10.7759\/cureus.96102","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:41:50Z","timestamp":1762306910000},"source":"Crossref","is-referenced-by-count":0,"title":["Effective Use of Mepolizumab in a Rare Case of Eosinophilic Granulomatosis With Polyangiitis Complicated by Pulmonary Tuberculosis"],"prefix":"10.7759","author":[{"given":"Yoshihiro","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeo","family":"Muro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1145257","article-title":"Eosinophilic granulomatosis with polyangiitis-advances in pathogenesis, diagnosis, and treatment","volume":"10","author":"Fijolek J","year":"2023","unstructured":"Fijolek J, Radzikowska E. Eosinophilic granulomatosis with polyangiitis-advances in pathogenesis, diagnosis, and treatment. Front Med (Lausanne). 2023, 10:1145257. 10.3389\/fmed.2023.1145257","journal-title":"Front Med (Lausanne)"},{"key":"ref2","unstructured":"Global tuberculosis report 2024. (2024). https.\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2024."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2015.04.022","article-title":"Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management","volume":"26","author":"Groh M","year":"2015","unstructured":"Groh M, Pagnoux C, Baldini C, et al.. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med. 2015, 26:545-53. 10.1016\/j.ejim.2015.04.022","journal-title":"Eur J Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1702079","article-title":"Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis","volume":"376","author":"Wechsler ME","year":"2017","unstructured":"Wechsler ME, Akuthota P, Jayne D, et al.. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med. 2017, 376:1921-32. 10.1056\/NEJMoa1702079","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330806","article-title":"The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis)","volume":"33","author":"Masi AT","year":"1990","unstructured":"Masi AT, Hunder GG, Lie JT, et al.. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990, 33:1094-100. 10.1002\/art.1780330806","journal-title":"Arthritis Rheum"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198403000-00001","article-title":"Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome","volume":"63","author":"Lanham JG","year":"1984","unstructured":"Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine (Baltimore). 1984, 63:65-81. 10.1097\/00005792-198403000-00001","journal-title":"Medicine (Baltimore)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1325299","article-title":"ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics","volume":"14","author":"Piga MA","year":"2023","unstructured":"Piga MA, Fraticelli P, Antonicelli L, et al.. ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics. Front Immunol. 2023, 14:1325299. 10.3389\/fimmu.2023.1325299","journal-title":"Front Immunol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jam.14478","article-title":"Recent updates on drug resistance in Mycobacterium tuberculosis","volume":"128","author":"Singh R","year":"2020","unstructured":"Singh R, Dwivedi SP, Gaharwar US, Meena R, Rajamani P, Prasad T. Recent updates on drug resistance in Mycobacterium tuberculosis. J Appl Microbiol. 2020, 128:1547-67. 10.1111\/jam.14478","journal-title":"J Appl Microbiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1086\/340618","article-title":"Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis","volume":"34","author":"Dooley KE","year":"2002","unstructured":"Dooley KE, Golub J, Goes FS, Merz WG, Sterling TR. Empiric treatment of community-acquired pneumonia with fluoroquinolones, and delays in the treatment of tuberculosis. Clin Infect Dis. 2002, 34:1607-12. 10.1086\/340618","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2005.056887","article-title":"Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas","volume":"61","author":"Wang JY","year":"2006","unstructured":"Wang JY, Hsueh PR, Jan IS, Lee LN, Liaw YS, Yang PC, Luh KT. Empirical treatment with a fluoroquinolone delays the treatment for tuberculosis and is associated with a poor prognosis in endemic areas. Thorax. 2006, 61:903-8. 10.1136\/thx.2005.056887","journal-title":"Thorax"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039721","article-title":"A case of eosinophilic granulomatosis with polyangiitis combined with pulmonary tuberculosis: a case report","volume":"103","author":"Lai Y","year":"2024","unstructured":"Lai Y, Xiao S, Shen Y. A case of eosinophilic granulomatosis with polyangiitis combined with pulmonary tuberculosis: a case report. Medicine (Baltimore). 2024, 103:e39721. 10.1097\/MD.0000000000039721","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00702.x","article-title":"The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis","volume":"226","author":"Cooper AM","year":"2008","unstructured":"Cooper AM, Khader SA. The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev. 2008, 226:191-204. 10.1111\/j.1600-065X.2008.00702.x","journal-title":"Immunol Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-078154","article-title":"CD4 T cells: fates, functions, and faults","volume":"112","author":"Zhu J","year":"2008","unstructured":"Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008, 112:1557-69. 10.1182\/blood-2008-05-078154","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.05.001","article-title":"Plasticity of CD4+ T cell lineage differentiation","volume":"30","author":"Zhou L","year":"2009","unstructured":"Zhou L, Chong MM, Littman DR. Plasticity of CD4+ T cell lineage differentiation. Immunity. 2009, 30:646-55. 10.1016\/j.immuni.2009.05.001","journal-title":"Immunity"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.8085","article-title":"Tuberculosis manifesting with significant peripheral eosinophilia: a case report and review of literature","volume":"11","author":"Damera AR","year":"2023","unstructured":"Damera AR, Gupta P, Farooqi S, et al.. Tuberculosis manifesting with significant peripheral eosinophilia: a case report and review of literature. Clin Case Rep. 2023, 11:e8085. 10.1002\/ccr3.8085","journal-title":"Clin Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/PHMT.S244155","article-title":"How common is eosinophilia in tuberculosis? Case report","volume":"11","author":"Haftu H","year":"2020","unstructured":"Haftu H, Tadese K, Gebrehiwot T, Gebregziabher H. How common is eosinophilia in tuberculosis? Case report. Pediatric Health Med Ther. 2020, 11:59-63. 10.2147\/PHMT.S244155","journal-title":"Pediatric Health Med Ther"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20210469","article-title":"Eosinophils are part of the granulocyte response in tuberculosis and promote host resistance in mice","volume":"218","author":"Bohrer AC","year":"2021","unstructured":"Bohrer AC, Castro E, Hu Z, et al.. Eosinophils are part of the granulocyte response in tuberculosis and promote host resistance in mice. J Exp Med. 2021, 218:e20210469. 10.1084\/jem.20210469","journal-title":"J Exp Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-051116-052350","article-title":"Th2 cells in health and disease","volume":"35","author":"Nakayama T","year":"2017","unstructured":"Nakayama T, Hirahara K, Onodera A, et al.. Th2 cells in health and disease. Annu Rev Immunol. 2017, 35:53-84. 10.1146\/annurev-immunol-051116-052350","journal-title":"Annu Rev Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2000.01291.x","article-title":"Pulmonary tuberculosis and serum IgE","volume":"122","author":"Ohrui T","year":"2000","unstructured":"Ohrui T, Zayasu K, Sato E, Matsui T, Sekizawa K, Sasaki H. Pulmonary tuberculosis and serum IgE. Clin Exp Immunol. 2000, 122:13-5. 10.1046\/j.1365-2249.2000.01291.x","journal-title":"Clin Exp Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/395378-effective-use-of-mepolizumab-in-a-rare-case-of-eosinophilic-granulomatosis-with-polyangiitis-complicated-by-pulmonary-tuberculosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:41:56Z","timestamp":1762306916000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/395378-effective-use-of-mepolizumab-in-a-rare-case-of-eosinophilic-granulomatosis-with-polyangiitis-complicated-by-pulmonary-tuberculosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.96102","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,4]]}}}